Роль мутаций в гене NF1 в спорадическом канцерогенезе for targeted
therapy of both neurofibromatosis type 1 and sporadic neoplasms with mutations of this gene
in the expression of miRNAs)
and designing their targeted
therapy using specific miRNAs as targets. This article
, it is necessary to develop an effective
therapy for NF1. The effectiveness of complex
therapy of NF1 with use
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа, a promising direction is NF1
therapy with STAT3 inhibitors and immune checkpoint inhibitors
Перспективы эпигенетической терапии плоскоклеточного рака головы и шеиProspects of epigenetic
therapy of head and neck squamous cell carcinoma
and for targeted
therapy of age-associated pathologies, including malignant neoplasms. In this regard, the study
in the general population is probable. The methods of NF1
therapy that are under investigation may become